FMR LLC Files Schedule 13G Regarding Xenon Pharmaceuticals
FMR LLC has filed a Schedule 13G form indicating a change in its ownership stake in Xenon Pharmaceuticals.
Stocks · News reference
Alaunos rose 21.8% after adopting amended bylaws; Cheetah Net led gainers, while Xenon dropped 27.6% after pausing study enrollment.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
FMR LLC has filed a Schedule 13G form indicating a change in its ownership stake in Xenon Pharmaceuticals.
Nucor Corporation reports strong operational progress, including the successful production start of its new automotive galvanizing line and continued on-schedule development of its West Virginia sheet mill.
Biohaven is advancing its Graves' disease treatment candidate, BHV-1300, with ongoing Phase 3 clinical trials and the presentation of new scientific data.
Bitcoin Treasury Corporation reported the repurchase and retirement of 99,500 common shares during October 2026 as part of its ongoing Normal Course Issuer Bid.
Nucor (NUE) is named Bull of the Day as the largest U.S. steel producer with record Q3 shipments, strong pricing rebound, and robust demand across multiple sectors, supported by rising analyst estimates and major growth projects. Prudential Financial (PRU) is named Bear of the Day despite beating Q3 earnings, as revenue declined, Japan operations remain suspended until January 2027 with significant earnings headwinds, and the company withdrew its growth guidance.
Abits Group Inc. has announced a strategic initiative to evaluate its existing U.S. facilities for potential expansion into artificial intelligence (AI) and high-performance computing (HPC) hosting services.